Normal view MARC view ISBD view

Safety efforts in pediatric drug development / Conor D. Byrne, editor.

Contributor(s): Byrne, Conor D.
Series: Pharmacology--research, safety testing and regulation series: Publisher: New York : Nova Science Publishers, c2010Description: xiv, 133 p. : ill. ; 23 cm.ISBN: 9781607415657 (hbk.); 1607415658 (hbk.).Subject(s): United States. Best Pharmaceuticals for Children Act | Pediatric pharmacology -- United States | Pediatrics -- United States -- Formulae, receipts, prescriptions -- Safety measures | Drug development -- United States -- Safety measuresDDC classification: 615.190083
Contents:
FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO.
Item type Current location Call number Copy number Status Notes Date due Barcode Remark
Main Collection TU External Storage-LCS
615.190083 SAF 2010 (Browse shelf) 1 Available SOPxx,31001,03,GR 5000103301 Please fill up online form at https://taylorslibrary.taylors.edu.my/services/external_storage1

Includes bibliographical references and index.

FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO.